Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Nature. 2019 May 1;569(7756):423–427. doi: 10.1038/s41586-019-1172-9

Extended Data Fig. 6: Loss of RB promotes alternative pathways toward gaining metastatic competency.

Extended Data Fig. 6:

(a) H&E photomicrographs of metastases that formed from KPRbTR/TR tumours.

(b) Immunofluorescence analysis of KP and KPRbTR/TR tumours for co-expression of HMGA2 and NKX2–1.

(c) IHC staining of serial sections from KP and KPRbTR/TR tumours for HMGA2 and FOXA2. Orange dotted lines outline mutually exclusive staining and red dotted lines outline co-expressing staining patterns. Quantification of staining pattern (right) showing percentage of HMGA2 positive tumours from KP (n=29 tumours from 3 mice) or KPRbTR/TR (n=37 tumours from 3 mice) mice that are positive or negative for FOXA2. Significance was determined by chi-square test (two-sided, p=1.1e-5).

(d) Histological analysis of KPRbTR/TR metastases. H&E and IHC for NKX2–1, HMGA2 and FOXA2 on serial sections from representative metastases that are NKX2–1 positive or negative. Results are tabulated in the adjacent graph.

(e) IHC staining of KP and KPRbTR/TR tumours for club (CC10) and neuroendocrine (synaptophysin) cell markers. For control and comparison, a synaptophysin positive small cell lung cancer from a p53flox/flox; Rbflox/flox; p130flox/flox mouse model is shown46.